Chemed Shares Gain on Full-Year Outlook

Dow Jones
04/24
 

By Elias Schisgall

 

Shares of Chemed rose after the company lifted its full-year guidance following revenue growth in the company's hospice business.

Shares were up 10% to $421.25 in after-hours trading Thursday. The stock closed up 2.6% at $382.97, down 10% this year.

The company, which owns a hospice care provider and a plumbing and drain cleaning business, said it now expects full-year adjusted earnings between $24.00 and $24.75 a share, up from a previous range of $23.25 to $24.25 a share.

Analysts polled by FactSet are expecting $23.88 a share.

The outlook lift was driven by the improved performance of the company's hospice business, Vitas, as well as Chemed's share repurchases in the first quarter, the company said.

Chemed on Thursday reported a profit of $66.3 million, or $4.84 a share, down from its profit of $71.8 million, or $4.86 a share, a year earlier.

Stripping out certain one-time items, the company logged adjusted earnings of $5.65 a share. Analysts were expecting $5.30 a share.

Sales and service revenues rose to $657.5 million from $646.9 million a year prior. Analysts were anticipating $649.8 million.

Vitas revenue rose 3.1% to $420 million. Roto-Rooter, the company's plumbing and drain-cleaning business, posted revenue of $237.5 million, down 0.9% year over year.

 

Write to Elias Schisgall at elias.schisgall@wsj.com

 

(END) Dow Jones Newswires

April 23, 2026 18:07 ET (22:07 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10